Advances in Hematology : Impact Factor & More
eISSN: 1687-9112pISSN: 1687-9104
Open AccessShare this on:
Key Metrics
CiteScore 
2.8
H-Index
36
SJR
Q3Hematology
SNIP
0.95
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Advances in Hematology
Advances in Hematology Journal Specifications
| Overview | |
| Publisher | Hindawi |
| Language | English |
| Article Processing Charges | USD 800 |
| Publication Time | 15 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Advances in Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Advances in Hematology
The Natural Coagulation Inhibitors, Inflammation, and Thrombotic Risk in Sickle Cell Patients in Cameroon: An Analytical Cross\u2010Sectional Study
- 18 May 2026
- Advances in Hematology
Outcomes of Diffuse Large B‐Cell Lymphoma in Older Adults Treated in Resource‐Constrained Settings
- 1 Jan 2026
- Advances in Hematology
Using a Shared Infusion Clinic for Outpatient Management of Sickle Cell Vaso‐Occlusive Crisis as a Strategy of Decreasing Emergency Department Visits
- 1 Jan 2026
- Advances in Hematology
Bispecific Antibodies in Hematologic Malignancies in the Outpatient and Community Settings.
- 1 Jan 2026
- Advances in hematology
Title not available
- 1 Jan 2026
- Advances in Hematology
Cardiac Amyloidosis AI‐ECG Model is Useful in Predicting Outcomes in Multiple Myeloma Patients Without Amyloidosis Undergoing Autologous Stem Cell Transplant
- 1 Jan 2026
- Advances in Hematology
The Natural Coagulation Inhibitors, Inflammation, and Thrombotic Risk in Sickle Cell Patients in Cameroon: An Analytical Cross\u2010Sectional Study
- 18 May 2026
- Advances in Hematology
Outcomes of Diffuse Large B‐Cell Lymphoma in Older Adults Treated in Resource‐Constrained Settings
- 1 Jan 2026
- Advances in Hematology
Using a Shared Infusion Clinic for Outpatient Management of Sickle Cell Vaso‐Occlusive Crisis as a Strategy of Decreasing Emergency Department Visits
- 1 Jan 2026
- Advances in Hematology
Bispecific Antibodies in Hematologic Malignancies in the Outpatient and Community Settings.
- 1 Jan 2026
- Advances in hematology
Title not available
- 1 Jan 2026
- Advances in Hematology
Cardiac Amyloidosis AI‐ECG Model is Useful in Predicting Outcomes in Multiple Myeloma Patients Without Amyloidosis Undergoing Autologous Stem Cell Transplant
- 1 Jan 2026
- Advances in Hematology
FAQs on Advances in Hematology
How many articles did Advances in Hematology publish last year? 
What is the eISSN & pISSN for Advances in Hematology?
What is Citescore for Advances in Hematology?
What is the H Index for Advances in Hematology ?
What is SNIP score for Advances in Hematology?
What is the SJR for Advances in Hematology?
Who is the publisher of Advances in Hematology?
